PharmacoLearnIt’s Important to Know!

← Biopharmaceutics and Pharmacokinetics Practicals

Extent of Plasma Protein Binding at Different Concentrations

protein binding concentration series
protein binding concentration series

1. Aim

To study year 4 biopharmaceutics 5 using supervised records and report the supported outcome. Actual case, sample, and result must be entered in the student record.

2. Requirements

Approved de-identified dataset or teaching case, current method, source identifiers, calibration and control records where relevant, graphing or calculation tool, supervisor, and privacy or safety procedure. Record the assigned sample and use approved software. Drug identity, dose, and acceptance criteria are to be recorded from the assigned current monograph or approved college method in the student record.

3. Theory

Binding may be concentration-dependent if sites saturate, but an apparent change can also reflect assay bias or nonspecific adsorption. The syllabus asks for a constant time condition. Compare the same drug across concentrations using one validated method and matched incubation time.

4. Procedure

  1. Confirm the syllabus entry, approved source, ethics or privacy requirements, and method.
  2. Record actual labels, units, time points, controls, and missing information without guessing.
  3. Work through the supervised case or dataset: Record total and unbound concentration at each verified level and constant time. Calculate binding fraction at each point and inspect recovery and control performance.
  4. Separate raw observations from calculations and check method suitability.
  5. Use verified formulae and local software only if the full dataset and method support them.
  6. State the supported result, limitations, and every missing item as Record here.

5. Observation and calculation

Student record field Entry
Case or product Record here
Method Record here
Observation Record here
Inference Record here
Supervisor check Record here
Outcome Record here

Assumed values or observations for practice only: Assumed low-level binding is 90% and assumed high-level binding is 80%. These invented percentages suggest a trend only; the mechanism cannot be inferred from these assumed values. All invented inputs and outputs are assumed, not a patient result or laboratory instruction.

6. Output or final result

Provide a labelled binding versus concentration plot and supervisor-reviewed conclusion. Record the supervised outcome here.

Teaching-lab safety: Clinical cases must be de-identified and supervised. Human or animal bioavailability work requires prior ethical authorization. No assumed example authorizes dosing or sampling. Software-dependent fitting belongs in the actual lab with its approved program.

This page is a supervised-activity guide; it does not report a completed case.

7. Sources

← Protein Binding of Highly and Poorly Bound DrugsBioavailability of Common Drugs in an Animal or Human Model →

Back to Biopharmaceutics and Pharmacokinetics Practicals · All Pharm D Practicals · Pharm D

Theory notes: Pharm D Year 4, 4.5 Biopharmaceutics and Pharmacokinetics